Page last updated: 2024-08-22

platinum and Cystadenocarcinoma, Papillary

platinum has been researched along with Cystadenocarcinoma, Papillary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Axtell, AE; Drake, RD; Fader, AN; Gehrig, PA; Gibbons, HE; Havrilesky, LJ; Huh, WK; O'Malley, DM; Tuller, E; Zanotti, KM	1

Other Studies

1 other study(ies) available for platinum and Cystadenocarcinoma, Papillary

Article	Year
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer, 2009, May-15, Volume: 115, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Disease-Free Survival; Female; Humans; Platinum; Recurrence; Retrospective Studies; Taxoids; Uterine Neoplasms	2009

Article

Year

Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.

Cancer, 2009, May-15, Volume: 115, Issue:10

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Disease-Free Survival; Female; Humans; Platinum; Recurrence; Retrospective Studies; Taxoids; Uterine Neoplasms

2009